Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.

Van De Sijpe G, Quintens C, Walgraeve K, et al. Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey. BMC Med Inform Decis Mak. 2022;22(1):48. doi:10.1186/s12911-022-01783-z.

Save
Print
April 13, 2022
Van De Sijpe G, Quintens C, Walgraeve K, et al. BMC Med Inform Decis Mak. 2022;22(1):48.
View more articles from the same authors.

Clinical decision support systems (CDSS) can help identify potential drug-drug interactions (DDI), but they can lead to alert fatigue and threaten patient safety. Based on an analysis of DDI alerts and survey data regarding physician experience using the DDI module in the CDSS, researchers identified barriers (i.e., lack of patient-specific characteristics and DDI-specific screening intervals) that contribute to false-positive alerts and alert fatigue.

Save
Print
Cite
Citation

Van De Sijpe G, Quintens C, Walgraeve K, et al. Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey. BMC Med Inform Decis Mak. 2022;22(1):48. doi:10.1186/s12911-022-01783-z.

Related Resources From the Same Author(s)